TITLE:
HPV Vaccine: Integrative Review of National and International Guidelines
AUTHORS:
Durval Silva Tavares Filho, Camille Marcele Resende Rocha, Elizabeth Bacha, Marcela Curvello Beltrão, Lusitânia Maria de Barros, Ádamo Newton Marinho Andrade, Fabiana Torres Valadares, Yasmin Nunes Machado
KEYWORDS:
Immunization, Prevention, Guidelines, HPV, Cervical Cancer
JOURNAL NAME:
Health,
Vol.14 No.12,
December
21,
2022
ABSTRACT: HPV (Human Papillomavirus) is an adenovirus of the Papillomaviridae family with approximately 200 subtypes (subdivided into low and high oncogenic risk groups), responsible for almost 99% of cervical cancers. Worldwide, there are more than 570,000 new cases and more than 311,000 women die each year from cervical cancer; for Brazil, the estimate is of more than 16,000 new cases per year. It is known that cervical cancer is one of the most easily preventable forms of cancer, as there is a highly effective vaccine against HPV. However, the morbidity and mortality rates correlated with human papillomavirus are still concerning, especially in less developed countries. In 2020, the WHO (World Health Organization) presented three goals to achieve by 2030 the worldwide extermination of cervical cancer; among these goals is vaccination. Is the world preparing for this battle? The present work is an integrative review, comparing national and international guidelines for HPV vaccination published in the last five years in the consulted databases, using the descriptors “cervical cancer”, “prevention” and “guideline” and the boolean operator “and”, from which nine articles were selected. The study made it possible to compare international and national guidelines for vaccination against HPV, showing that developed countries implemented the HPV vaccine longer ago and follow the WHO recommendations more rigorously and effectively than underdeveloped or developing countries. Adopting a single dose as a strategy, as suggested by the WHO in April 2022, could be an important step towards increasing coverage and providing protection for a greater number of girls who do not have access to HPV immunization.